scispace - formally typeset
W

William S. Robinson

Researcher at Stanford University

Publications -  118
Citations -  8017

William S. Robinson is an academic researcher from Stanford University. The author has contributed to research in topics: Virus & Hepatitis B virus. The author has an hindex of 50, co-authored 118 publications receiving 7950 citations. Previous affiliations of William S. Robinson include National Institutes of Health & City University of New York.

Papers
More filters
Journal ArticleDOI

DNA polymerase associated with human hepatitis B antigen.

TL;DR: DNA polymerase activity was detected in each of eight preparations of concentrated human hepatitis B antigen (HBAg) rich in Dane particles prepared by high-speed centrifugation of antigen-positive human plasma and in none of seven control preparations prepared in the same way from HBAg-negative plasma.
Journal ArticleDOI

Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis

TL;DR: Parenteral interferon therapy was associated with a rapid and reproducible fall in all Dane-particle markers in four patients with chronic hepatitis B infection and chronic active hepatitis and may be useful in limiting carrier infectivity or eradicating chronic infection.
Journal ArticleDOI

A virus in Beechey ground squirrels that is related to hepatitis B virus of humans.

TL;DR: A virus, with many of the unique characteristics of human hepatitis B virus, has been found in Beechey ground squirrels in northern California and is a member of the virus group that includes HBV and the virus recently found in woodchucks in the eastern United States and named woodchuck hepatitis virus.
Journal ArticleDOI

DNA of a Human Hepatitis B Virus Candidate

TL;DR: In this article, the authors used electron microscopy to identify double-stranded DNA molecules approximately 0.78 ± 0.09 cm in length and a molecular weight of around 1.6 x 10(6).
Journal ArticleDOI

Survival in chronic hepatitis B. An analysis of 379 patients.

TL;DR: Survival data from 379 patients with chronic hepatitis B were analyzed to determine life expectancy for the patient from the time of first contact, and a multivariate analysis found age of 40 years or more, total bilirubin level of 1.5 mg/dLor more, ascites, and spider nevi to be factors that identified patients at a higher risk of death.